Ibrutinib’s Impact on the Tumor Microenvironment: Mechanisms and Clinical Insights
Explore how ibrutinib reshapes the tumor microenvironment, its immune effects, clinical evidence, combination strategies, and future research directions.
Read MoreTag: CLL
15
Oct